PGS/PGD Counseling Considerations | Module Series

13 April 2017

In this webinar, Holly Snyder, MS, CGC, a Senior Genetic Counselor at Illumina, provides supplemental education and support to in vitro fertilization (IVF) clinics. Hear a brief overview of some key considerations to include when discussing preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS) with patients. This module is intended to provide basic information and is for general educational purposes only.   View related information View related videos Next-generation Sequencing's Potential Benefits for PGS with Dagan Wells Incorporating Preimplantation Genetic Testing into Today’s Fertility Practice PGS Advances IVF: Dr. Robert Anderson Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on